Optimizing chimeric antigen receptor (CAR) T cell therapy for adult patients with relapsed or refractory (r/r) acute lymphoblastic leukemia (ALL).Noelle V. Frey, David L. Porter, James K. Mangan et al.|Journal of Clinical Oncology|2016Cited by 43
Results of a Multicenter Open-Label Randomized Trial Evaluating Infusion Duration of Zoledronic Acid in Multiple Myeloma Patients (the ZMAX Trial)James R. Berenson, Robert C. Collins, Solveig G. Ericson et al.|The Journal of Supportive Oncology|2011Cited by 10
93: Outcome with a thiotepa containing regimen and autologous HSCT in patients with NHLAaron Cumpston, Solveig G. Ericson, Deirdre Bulian et al.|Transplantation and Cellular Therapy|2007Cited by 1